Physician Assistant Exam Review

  • About
  • Contact
  • Blueprint
  • Blueprint
  • Products
  • About
  • Contact
  • Daily Emails
You are here: Home / Genitourinary / 143 Bladder disorders – How you’ll see them on your exam

143 Bladder disorders – How you’ll see them on your exam

https://traffic.libsyn.com/physicianassistantexamreview/PAER_143_GU_Bladder.mp3

Podcast: Play in new window | Download

Urinary Incontinence

  • Involuntary loss of urine due to dysfunction of bladder storage, outlet control, or both. Classified as stress, urge (overactive bladder), overflow, functional, or mixed types.
  • Very common in women after menopause or childbirth. Overflow type occurs more often in men with benign prostatic hyperplasia or neurologic disease.

Clinical Presentation

  • Stress Incontinence: Leakage with increased intra-abdominal pressure (cough, sneeze, laugh); common postpartum or post-menopause.
    The question stem would likely describe a postmenopausal woman who reports urine leakage when she exercises, laughs, or coughs.

  • Urge Incontinence: Sudden, strong urge to void with inability to reach the toilet in time; caused by overactive detrusor muscle; nocturia is common.
    The question stem would likely describe a patient who feels an abrupt urge to urinate and cannot make it to the bathroom in time, often awakening several times at night.

  • Overflow Incontinence: Dribbling and incomplete emptying due to bladder outlet obstruction or detrusor underactivity; seen with benign prostatic hyperplasia, neurogenic bladder, or diabetes.
    The question stem would likely describe an older man with benign prostatic hyperplasia who reports dribbling urine and a sensation of incomplete emptying.

  • Functional Incontinence: Normal bladder function but impaired mobility or cognition (dementia, post-stroke).
    The question stem would likely describe an elderly nursing home resident with dementia who is unable to reach the bathroom before urinating.

  • Mixed Incontinence: Combination of stress and urge symptoms; common in older women.
    The question stem would likely describe an older woman with both leakage when coughing and episodes of urgency.

Diagnostics

  • Urinalysis and urine culture: First step to rule out urinary tract infection.
  • Serum BUN and creatinine: Assess renal function in chronic or severe cases.
  • Post-void residual measurement:
    • Less than 50 mL is normal.
    • Greater than 200 mL suggests overflow incontinence.
    • In older adults, a residual up to about 100 mL can be normal.
  • Bladder stress (cough) test: With a full bladder, immediate leakage after a single cough confirms stress incontinence.
  • Voiding diary (48–72 hours) and medication review: Identify transient or medication-related causes (e.g., diuretics, anticholinergics, calcium-channel blockers, opioids, alpha-blockers).
  • Urodynamic studies: A small catheter measures bladder pressure and urine flow during filling and emptying; used to identify detrusor overactivity, impaired contractility, or outlet obstruction when the diagnosis is uncertain or before surgery.
  • Neurologic evaluation: Consider if diabetic neuropathy or spinal cord involvement is suspected.

Treatment

Step 1: Behavioral and Lifestyle Measures

  • Bladder training: Scheduled voiding at gradually longer intervals to increase bladder capacity and reduce urgency episodes.
  • Timed voiding and fluid management; limit caffeine, alcohol, and bladder irritants.
  • Kegel (pelvic floor) exercises for stress incontinence.
  • Weight loss and smoking cessation.
  • Topical vaginal estrogen for postmenopausal atrophic urethritis or vaginitis contributing to symptoms.

Step 2: Pharmacologic Management (Type-Specific)

  • Urge / Overactive bladder:
    • Antimuscarinic agents (oxybutynin, tolterodine) reduce detrusor contractions. Avoid in gastric retention or untreated narrow-angle glaucoma and in patients with high post-void residuals.
    • Beta-3 adrenergic agonist (mirabegron) relaxes bladder muscle; use if antimuscarinics are not tolerated. Avoid in uncontrolled hypertension.
  • Overflow incontinence:
    • Alpha-adrenergic blockers (tamsulosin, terazosin) relieve obstruction in benign prostatic hyperplasia.
    • Intermittent self-catheterization as needed.
    • Bethanechol may help stimulate detrusor contraction in neurogenic bladder (limited use).
  • Stress incontinence:
    • Pelvic floor therapy first-line.
    • Pseudoephedrine (alpha-agonist) may increase urethral tone but is rarely used.
    • Pessary can be used when pelvic organ prolapse contributes or surgery is undesired.
  • Functional incontinence:
    • Environmental modifications, scheduled toileting, and mobility support.

Step 3: Surgical and Procedural Options

  • Stress incontinence: Mid-urethral sling or urethropexy for refractory cases.
  • Overflow incontinence: Surgical relief of outlet obstruction (e.g., transurethral resection of the prostate).
  • Refractory urge/overactive bladder: Posterior tibial nerve stimulation, sacral neuromodulation, or intradetrusor botulinum toxin after failure of conservative or medication therapy.

Exam Keys

  • Leakage with coughing or sneezing → Stress incontinence → Pelvic floor therapy → Sling procedure if refractory. Add topical estrogen for atrophic changes or use a pessary if prolapse contributes.
  • Sudden urge and nocturia → Urge incontinence → Oxybutynin or bladder training. If refractory, consider posterior tibial nerve stimulation, sacral neuromodulation, or intradetrusor botulinum toxin. Exclude urinary retention before treatment.
  • Dribbling, weak stream, high post-void residual, benign prostatic hyperplasia history → Overflow incontinence → Tamsulosin or intermittent catheterization → TURP if obstruction persists.
  • Incontinence in dementia or immobility → Functional incontinence → Scheduled toileting and assistance.
  • Medication associations: diuretics can precipitate urgency; anticholinergics, calcium-channel blockers, and opioids can cause retention or overflow; alpha-blockers can worsen stress incontinence in women.
  • Avoid antimuscarinic drugs in overflow incontinence—they can worsen urinary retention.

Overactive Bladder (OAB)

  • Urgency, frequency, and nocturia with or without urge incontinence, in the absence of infection or another identifiable cause.
  • Caused by detrusor muscle overactivity, leading to involuntary bladder contractions and reduced control.
  • Common in older adults; chronic but not life-threatening.

Clinical Presentation

  • Urinary urgency, frequent small-volume voids (more than 7–8 times per day), and nocturia.
  • May have urge incontinence if unable to reach the toilet in time.
  • No dysuria, hematuria, or fever—these findings suggest infection or another etiology.
  • The question stem would likely describe an older adult who reports a sudden, strong urge to urinate, frequent small voids during the day and night, and no signs of infection.

Diagnostics

  • Urinalysis and culture: Rule out urinary tract infection.
  • Post-void residual: Normal (less than 50 mL).
  • Voiding diary: Tracks voiding frequency, timing, and fluid intake.
  • Medication review: Identify contributing agents (diuretics, caffeine, alcohol).
  • Urodynamic studies: May show uninhibited detrusor contractions; reserved for unclear or refractory cases.
  • Cystoscopy: Consider only if hematuria or pelvic pain is present.

Treatment

Step 1: Behavioral and Lifestyle Measures

  • Bladder training: Timed voiding with gradually increasing intervals to improve bladder capacity and control.
  • Pelvic floor (Kegel) exercises: Strengthen muscles controlling detrusor activity.
  • Limit caffeine, alcohol, and bladder irritants.
  • Weight reduction and constipation management.

Step 2: Pharmacologic Management

  • Antimuscarinics: Oxybutynin, tolterodine, solifenacin—reduce detrusor contractions. Avoid in glaucoma, gastric retention, or elevated post-void residuals.
  • Beta-3 agonist: Mirabegron or vibegron—relax bladder muscle; alternative when antimuscarinics are not tolerated. Avoid in uncontrolled hypertension.

Step 3: Procedural and Surgical Options

  • Posterior tibial nerve stimulation (noninvasive) or sacral neuromodulation (implant) for refractory cases.
  • Intradetrusor botulinum toxin injections reduce detrusor contractions; effects last about 6–9 months.
  • Augmentation cystoplasty: Rare; reserved for severe, refractory cases.

Exam Keys

  • Urgency, frequency, nocturia without infection → Overactive bladder → Bladder training and Kegel exercises first-line.
  • Behavioral therapy fails → Add oxybutynin or tolterodine.
  • Antimuscarinics not tolerated → Use mirabegron.
  • Persistent symptoms → Posterior tibial nerve stimulation or botulinum toxin.
  • Normal post-void residual distinguishes OAB from overflow incontinence.
  • Absence of dysuria or hematuria differentiates from urinary tract infection or bladder cancer.

Bladder Prolapse (Cystocele)

  • Descent of the bladder into the anterior vaginal wall due to weakened pelvic floor or loss of connective tissue support.
  • Common in postmenopausal women, those with multiple vaginal deliveries, or chronic increased intra-abdominal pressure (obesity, cough, constipation).

Clinical Presentation

  • Vaginal “bulge,” pelvic pressure, or heaviness, worse with standing or straining.
  • May have urinary frequency, incomplete emptying, or stress incontinence.
  • Exam shows anterior vaginal wall protrusion, accentuated by Valsalva.
  • The question stem would likely describe a postmenopausal woman with a vaginal bulge and urine leakage when coughing or standing, relieved when lying down.

Diagnostics

  • Pelvic exam: Confirms diagnosis; bladder descends into the anterior vaginal wall during Valsalva.
  • Post-void residual: May be increased if incomplete emptying.
  • Urinalysis: Rule out UTI.
  • Imaging rarely needed—clinical diagnosis.

Treatment

Mild: Pelvic floor (Kegel) exercises, topical vaginal estrogen, pessary support.
Moderate/Severe: Surgical repair with anterior colporrhaphy (bladder suspension).
Avoid heavy lifting, manage chronic cough or constipation.

Exam Keys

  • Vaginal bulge or pelvic pressure → Cystocele.
  • Urinary symptoms plus anterior vaginal wall protrusion → Bladder prolapse.
  • First-line: Kegel exercises or pessary.
  • Definitive: Anterior colporrhaphy.
  • Distinguish from rectocele (posterior wall bulge, constipation) and uterine prolapse (uterine descent).

Cryptorchidism

  • One or both testes absent from the scrotum due to failure of descent.
  • Most common congenital GU abnormality; usually unilateral.
  • Increases risk of infertility, testicular torsion, and malignancy (seminoma).

Risk Factors

  • Premature birth
  • Low birth weight
  • Family history of undescended testes

Clinical Presentation

  • Found on routine pediatric exam as an empty or underdeveloped hemiscrotum.
  • Testis may be nonpalpable or located in the inguinal canal or abdomen.
  • The question stem would likely describe an infant boy with one side of the scrotum empty on physical exam.

Diagnostics

  • Physical exam: Provider unable to palpate one or both testicles.
  • Ultrasound: Used if the testis is nonpalpable.
  • MRI: Considered if ultrasound is inconclusive.
  • Differentiate from retractile testis, which can be manipulated into the scrotum.

Treatment

  • Initially watchful waiting: Most testes descend by 6–12 months of age.
  • If persistent after 6 months (definitely by 1 year): → Orchiopexy.
  • hCG injections may stimulate testosterone and descent but are less reliable.
  • Early surgery (<12–24 months) reduces risk of infertility and malignancy.

Exam Keys

  • Infant with empty scrotum on one side → Observe until 6 months → Orchiopexy if persistent.
  • Increased risk of testicular torsion and cancer even after correction.
  • Bilateral nonpalpable testes → Evaluate for endocrine or chromosomal disorder.
  • Retractile testis is normal variant—no treatment needed.

Peyronie Disease

  • Fibrous scar tissue formation within the tunica albuginea of the penis causes curvature or deformity during erection.
  • May lead to painful erections and difficulty with intercourse.
  • Thought to result from microvascular trauma and abnormal wound healing.

Clinical Presentation

  • Curved or bent penis during erection.
  • Penile pain or discomfort with erection.
  • Erectile dysfunction in some cases.
  • The question stem would likely describe a middle-aged man with progressive penile curvature and painful erections that interfere with sexual activity.

Diagnostics

  • Clinical diagnosis based on exam and history.
  • Ultrasound may be used to confirm presence and extent of fibrous plaque.

Treatment

  • Observation: Mild cases may resolve spontaneously.
  • Intralesional injections: Verapamil, collagenase (Xiaflex), or corticosteroids may reduce plaque size and curvature.
  • Surgery: Indicated for severe deformity or when conservative measures fail (e.g., plaque excision, grafting, or plication).

Exam Keys

  • Penile curvature with pain during erection → Peyronie disease.
  • Caused by fibrous plaque in tunica albuginea.
  • Mild: Observation.
  • Moderate to severe: Intralesional therapy or surgical correction.
  • Distinguish from congenital curvature (present since adolescence, no pain).

Genitourinary Trauma

  • Injury to the kidneys, ureters, bladder, or urethra from blunt or penetrating trauma.
  • Common mechanisms: motor vehicle accidents, pelvic fractures, or straddle injuries.
  • May cause hematuria, urinary retention, or flank/perineal bruising.

Clinical Presentation

  • Renal trauma: Flank pain, ecchymosis, gross or microscopic hematuria after blunt injury.
  • Bladder injury: Suprapubic pain, inability to void, distended abdomen, hematuria—often with pelvic fracture.
  • Urethral injury: Blood at urethral meatus, perineal bruising, high-riding or nonpalpable prostate.
  • Penile trauma: Rapid swelling or deformity after sexual activity → suspect penile fracture (tunica albuginea rupture).
  • The question stem would depend on the type of trauma.

Diagnostics

  • Urinalysis: Check for hematuria.
  • CT abdomen/pelvis with contrast: For suspected renal or bladder trauma.
  • Retrograde urethrogram (RUG): Always perform before catheterization if urethral injury is suspected (blood at meatus, pelvic fracture).
  • Cystography (retrograde cystogram): To confirm bladder rupture.

Treatment

  • Renal trauma: Conservative if stable; surgery for vascular injury or severe laceration.
  • Bladder rupture:
    • Extraperitoneal → Foley catheter drainage.
    • Intraperitoneal → Surgical repair.
  • Urethral injury: Surgical repair after suprapubic catheter placement.
  • Penile fracture: Surgical repair of tunica albuginea.

Exam Keys

  • Blood at urethral meatus → Do NOT insert Foley catheter → Perform retrograde urethrogram first.
  • Gross hematuria after trauma → CT abdomen/pelvis with contrast.
  • Pelvic fracture + urinary retention → Suspect urethral injury.
  • Suprapubic pain + distension + pelvic fracture → Bladder rupture.
  • Sudden penile pain + “snapping” during intercourse → Penile fracture → Surgical repair.

Vesicoureteral Reflux (VUR)

  • Retrograde flow of urine from the bladder into the ureters and kidneys due to an incompetent vesicoureteral junction (UVJ).
  • Primary VUR: Congenital defect (short intramural ureter, familial tendency).
  • Secondary VUR: Results from increased bladder pressure due to obstruction or dysfunction (posterior urethral valves, neurogenic bladder, recurrent infection).
  • Goal of management: Prevent infection and renal scarring, not just correct reflux.

Clinical Presentation

  • Recurrent febrile urinary tract infections or pyelonephritis in infants and children.
  • May present with poor growth, flank pain, or hypertension if chronic.
  • Often discovered incidentally after evaluation for prenatal hydronephrosis or sibling screening.
  • The question stem would likely describe a young child with recurrent febrile UTIs and renal ultrasound showing hydronephrosis or cortical scarring.

Diagnostics

  • Urinalysis and culture: Confirm infection.
  • Renal ultrasound: Initial study for hydronephrosis or renal scarring.
  • Voiding cystourethrogram (VCUG): Diagnostic test of choice; shows retrograde urine flow during voiding.
  • DMSA renal scan: Evaluates renal cortical scarring.
  • Grading (I–V):
    • I–II: Reflux into ureter ± renal pelvis without dilation
    • III: Mild/moderate dilation
    • IV–V: Severe dilation and tortuosity

Treatment

  • Grades I–II (mild): Observation ± low-dose antibiotic prophylaxis; most resolve spontaneously.
  • Grades III–V or recurrent febrile UTIs: Continuous antibiotic prophylaxis (TMP-SMX, nitrofurantoin, or cephalexin).
  • Endoscopic Deflux injection (dextranomer/hyaluronic acid): Minimally invasive treatment for moderate/severe reflux refractory to medical therapy.
  • Surgical ureteral reimplantation: For persistent high-grade or complicated cases (renal scarring, recurrent pyelonephritis).
  • Supportive measures: hydration, timed/double voiding, constipation prevention, and perineal hygiene.

Exam Keys

  • Recurrent febrile UTI in a child → Order VCUG.
  • Low-grade: Observation ± prophylactic antibiotics.
  • High-grade or recurrent infection: Endoscopic Deflux injection or surgical correction.
  • Major risk → renal scarring → hypertension → CKD.
  • ~25% of siblings may also have VUR (familial tendency).
  • Focus on preventing infection and renal damage rather than eliminating reflux itself.
  • Blueprint
  • Products
  • About
  • Contact
  • Daily Emails

logo Privacy Policy | Fulfillment Policy | Terms of Service | Web design by OptimWise

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}